US Stock MarketDetailed Quotes

ADMA ADMA Biologics

Watchlist
  • 21.440
  • +0.070+0.33%
Trading Nov 21 13:46 ET
5.07BMarket Cap79.41P/E (TTM)

ADMA Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ADMA Biologics Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
105.85M
119.84M
+13.99M
Beat Est.
+57.34%
+78.13%
+13.22%
EPS
0.13
0.15
+0.02
Beat Est.
+1200.00%
+1400.00%
+15.38%
Analyst Rating
Buy

Nov 8, 2024

ADMA Biologics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 112.901M--
--2024/Q4-- / 113.400M--
Nov 7, 20242024/Q3119.839M / 105.850M--
Aug 8, 20242024/Q2107.191M / 86.413M--
May 9, 20242024/Q181.875M / 77.275M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 112.901M--
--2024/Q4-- / 113.400M--
Nov 7, 20242024/Q3119.839M / 105.850M--
Aug 8, 20242024/Q2107.191M / 86.413M--
May 9, 20242024/Q181.875M / 77.275M--

Unlock Free Earnings Estimates

ADMA Biologics Earnings Reports

  • ADMA Biologics | 10-Q: Q3 2024 Earnings Report

    Nov 7 17:08 ET

  • ADMA Biologics | 10-Q: Q2 2024 Earnings Report

    Aug 8 17:06 ET

  • ADMA Biologics | 10-Q: Q1 2024 Earnings Report

    May 9 17:05 ET

  • ADMA Biologics | 10-K: FY2023 Annual Report

    Feb 28 17:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data